Skip to content

Effect of Blood Flow Restricted Aerobic Exercise in Type 2 Diabetes Mellitus

Investigation of the Effect of Blood Flow Restricted Aerobic Exercise on Cardiorespiratory Fitness and Blood Glucose in Type 2 Diabetes Mellitus

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04315519
Enrollment
28
Registered
2020-03-19
Start date
2020-04-01
Completion date
2021-09-01
Last updated
2020-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Blood Flow Restricted Exercise, Type 2 Diabetes, Aerobic Exercise

Brief summary

Comparison of the effect of low intensity blood flow restricted aerobic exercise on glycemic and respiratory status with moderate aerobic exercise.

Detailed description

The aim of this study is to show, whether the effect of low-intensity aerobic exercise training combined with blood flow restriction is similar on both glycemic and cardiorespiratory status compared to moderate-intensity continuous aerobic exercise, in individuals with type 2 diabetes mellitus .

Interventions

OTHERExercise

Aerobic Exercise

Sponsors

Recep Tayyip Erdogan University Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Having Type 2 Diabetes * Not have been recruited any exercise programme for 6 months * Volunteering to participate in the study

Exclusion criteria

* Nephropathy * Retinopathy * Have had myocardial infarction at least 6 months ago * Stable or unstable angina pectoris * The presence of peripheral artery disease * Resting blood pressure above 160/100 mmHg * Body mass index over 35 kg / m2 * History of deep vein thrombosis, pulmonary embolism or stroke

Design outcomes

Primary

MeasureTime frameDescription
Blood Glucoseup to 12 monthsFasting Blood Glucose, this data will be collected from the individulas routine biochemistry tests
HbA1cup to 12 monthsGlycated hemoglobin, This data will be collected from teh individulas during routine test
Blood Glucose in Oral glucose Tolerance TestUp to 12 monthsBlood Glucose in Oral glucose Tolerance Test, this data will be collected from the individuals during routine tests.
Cardiorespiratory FitnessUp to 12 monthsMaximal Power in Maximal Exercise Test, this test will be performed in incremental cardiopulmonary exercise test in cycle ergometer.

Secondary

MeasureTime frameDescription
Fat Free MassUp to 12 monthsFat Free Mass will be calculated by bioimpedance analysis, this data will be collected with all individulas to see the changes with the muscle mass, the test will be The test will be carried out with a 4-channel test device, both hand and foot, to eveluate changes segmentally.
The Strength of Hamstring MuscleUp to 12 monthsThe Strength of Hamstring Muscle, this data will be collected before the intervention eith a manual muscle tester, in sitting position.
The Strength of Quadriceps MuscleUp to 12 monthsThe Strength of Quadriceps Muscle, this data will be collected before the intervention eith a manual muscle tester, in sitting position.

Contacts

Primary ContactElif SAHIN
fztelifsahin61@gmail.com+90 (464) 344 20 45

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026